Optimus Pharma launched a new Anti-Parkinson’s Drug in India
![](https://republicnewstoday.com/wp-content/uploads/2021/04/Safinamide-ANI-Release-768x500.jpeg)
Hyderabad (Telangana) [India], April 26: Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson’s drug Safinamide. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes. The burdens…